Journal
NANOMEDICINE
Volume 7, Issue 8, Pages 1133-1148Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/NNM.11.189
Keywords
antiangiogenic therapy; brain tumor; cancer; glioma; nanoparticles; near-infrared; thermal therapy; VEGF
Funding
- National Science Foundation [EEC-0647452]
- NIH [R21 CA118788]
- Hope Street Kids
- NIH MSCIDA [3 U10 HD037242-08S1]
Ask authors/readers for more resources
Aim: To develop nanoshells for vascular-targeted photothermal therapy of glioma. Materials & methods: The ability of nanoshells conjugated to VEGF and/or poly(ethylene glycol) (PEG) to thermally ablate VEGF receptor-2-positive endothelial cells upon near-infrared laser irradiation was evaluated in vitro. Subsequent in vivo studies evaluated therapy in mice bearing intracerebral glioma tumors by exposing tumors to near-infrared light after systemically delivering saline, PEG-coated nanoshells, or VEGF-coated nanoshells. The treatment effect was monitored with intravital microscopy and histology. Results: VEGF-coated but not PEG-coated nanoshells bound VEGF receptor-2-positive cells in vitro to enable targeted photothermal ablation. In vivo, VEGF targeting doubled the proportion of nanoshells bound to tumor vessels and vasculature was disrupted following laser exposure. Vessels were not disrupted in mice that received saline. The normal brain was unharmed in all treatment and control mice. Conclusion: Nanoshell therapy can induce vascular disruption in glioma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available